Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

How a new kind of drug could change the future of Alzheimer’s

How a new kind of drug could change the future of Alzheimer’s

FromThe Decibel


How a new kind of drug could change the future of Alzheimer’s

FromThe Decibel

ratings:
Length:
22 minutes
Released:
Apr 16, 2024
Format:
Podcast episode

Description

There are an estimated 650,000 cases of dementia in Canada right now. The last 20 years of research into the treatment of Alzheimer’s have been, as one expert put it, “agonizing.” But a new drug was approved in the United States and is being tested in Canada to see if it can delay or slow the progression of Alzheimer’s symptoms. And it’s giving researchers and patients some hope that a breakthrough could be on the way.Kelly Grant, health reporter for The Globe, has been looking at this drug more closely. She’s on the show today to tell us what these trials mean for patients and the future of Alzheimer’s research.Questions? Comments? Ideas? Email us at thedecibel@globeandmail.com
Released:
Apr 16, 2024
Format:
Podcast episode

Titles in the series (100)

Context is everything. Join us Monday to Friday for a Canadian daily news podcast from The Globe and Mail. Explore a story shaping our world, in conversation with reporters, experts, and the people at the centre of the news.